Mark Wisniewski joined UCLA TDG in September 2017 as the Senior Director of BioPharmaceuticals. Prior to joining UCLA TDG, Mark was the Head of Special Projects at Prolacta Bioscience, leading the strategic planning and business development functions. He was also a Principal Advisor to the National Institutes of Health SBIR Commercialization Accelerator Program which provides business strategy, product commercialization, fund raising and strategic partnership guidance to hundreds of biotech and life science companies. Mark was previously at Baxter Healthcare where he held positions in business development, strategic planning, marketing and R&D. Mark received his MBA from the UCLA Anderson School of Management and his Masters of Immunology and Microbiology at the UCLA School of Medicine.